These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 533263)

  • 41. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serial measurement of serum levels of amikacin. Value in therapy].
    Granthil C; Savin B; Charrel CT; Martin C; Gouin F; François G
    Ann Anesthesiol Fr; 1981; 22(2):207-11. PubMed ID: 6115609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
    Khan AJ; Evans HE; Jhaveri R; Chang CT; Hochstein L
    Pediatrics; 1976 Dec; 58(6):873-6. PubMed ID: 995517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Amikacin therapy for serious infections in hematopoietic disorders (author's transl)].
    Fujii H; Shimizu T
    Jpn J Antibiot; 1981 Jun; 34(6):841-51. PubMed ID: 7289039
    [No Abstract]   [Full Text] [Related]  

  • 46. Amikacin concentration in the cerebrospinal fluid of children with acute bacterial meningitis.
    Trujillo H; Salgado H; Uribe A; Agudelo N; Zapata CT; Luisa de Vidal E; Zuluaga AI
    J Int Med Res; 1979; 7(1):45-51. PubMed ID: 421964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment.
    Lanao JM; Navarro AS; Dominguez-Gil A; Tabernero JM; Rodriguez IC; Gonzalez Lopez A
    J Antimicrob Chemother; 1983 Nov; 12(5):481-8. PubMed ID: 6671925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
    Matzke GR; Salem N; Bockbrader H; Blevins R
    Proc Clin Dial Transplant Forum; 1980; 10():302-4. PubMed ID: 7346850
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experiences with intravenous drip infusion therapy of amikacin for severe infections in patients of hematological disorder].
    Hanada S; Kodama M; Iwahashi M; Uematsu T; Utsunomiya A; Kato Y; Nishioka K; Nomura K; Hashimoto S; Kikuchi H; Matsumoto T; Matsumoto M; Yunoki K
    Jpn J Antibiot; 1982 May; 35(5):1249-53. PubMed ID: 7131757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of amikacin concentrations in perilymph and plasma of continuously infused guinea pigs.
    Desjardins-Giasson S; Beaubien AR
    Antimicrob Agents Chemother; 1984 Jul; 26(1):87-90. PubMed ID: 6476817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amikacin pharmacokinetics in young men with pneumonia.
    Bauer LA; Blouin RA
    Clin Pharm; 1982; 1(4):353-5. PubMed ID: 7185529
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay.
    Plantier J; Forrey AW; O'Neill MA; Blair AD; Christopher TG; Cutler RE
    J Infect Dis; 1976 Nov; 134 SUPPL():S323-30. PubMed ID: 993625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
    Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
    Brown MP; Gronwall RR; Martinez DS; Beal C
    Am J Vet Res; 1986 Feb; 47(2):453-4. PubMed ID: 3954234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experience of amikacin intravenous drip infusion (author's transl)].
    Tsuchiya J; Miyao S; Shinonome S; Takakuwa M; Mou M
    Jpn J Antibiot; 1980 Jul; 33(7):711-5. PubMed ID: 6935444
    [No Abstract]   [Full Text] [Related]  

  • 57. Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study.
    Dyas A; Wise R; Pijck J; Hallynck T; Acar J; Adam D; Cadorniga R; Wenk M; Soep HH
    J Antimicrob Chemother; 1983 Oct; 12(4):371-6. PubMed ID: 6643332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Aminoglycoside drip intravenous infusion for severe infections due to leukemia and hematopoietic tumor patients (author's transl)].
    Fujioka S; Asai T; Ito K; Sugiura Y; Oh H
    Jpn J Antibiot; 1981 Jan; 34(1):7-15. PubMed ID: 7241808
    [No Abstract]   [Full Text] [Related]  

  • 59. Amikacin sulfate levels in human serum and bile.
    Bermúdez RH; Lugo A; Ramírez-Ronda CH; Amadeo JA; Morales J
    Antimicrob Agents Chemother; 1981 Feb; 19(2):352-4. PubMed ID: 7347566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amikacin: pharmacology, indications and cautions for use, and dose recommendations.
    Philips JB; Cassady G
    Semin Perinatol; 1982 Apr; 6(2):166-71. PubMed ID: 7048537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.